A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
Clinical trial NCT03907202 · TERMINATED
Trial details
- NCT number
- NCT03907202
- Sponsor
- KeyBioscience AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2019-12-03
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.